Across the UK, thousands of National Health Service (NHS) patients are facing increasingly long delays in receiving vital blood test results, with some waiting several weeks for answers that could determine urgent treatment plans. These backlogs, caused by a combination of IT failures, supply chain disruptions, and workforce shortages, are straining an already overburdened healthcare system.
The headline of a breaking news article in The Times reads: “Thousands of patients at risk after blood tests lost in IT failure.” A research article on Needle.Tube confirms the potential serious consequences delayed results can have: “When it comes to providing quality healthcare, timely and accurate lab results are crucial.” The information obtained from laboratory tests plays a key role in diagnosing and treating patients. However, when lab results are delayed or inaccurate, it can have serious consequences for patient care.
The significant delays in processing blood tests are due to a combination of factors. An IT failure at Leeds Teaching Hospitals NHS Trust compromised tens of thousands of blood test results, affecting over 75 GP practices in West Yorkshire. This incident resulted in lost, miscoded, and delayed test results, leading to a backlog of approximately 10 000 test results.
Additionally, a supply chain failure at Roche, a major diagnostics company, caused a significant drop in processing capacity. The company moved to a new warehouse in September 2024, leading to logistical issues that affected the availability of various diagnostic tests, including those for cancer, heart disease, and thyroid function.
Patients awaiting blood tests in affected areas are experiencing extended waiting times. The backlog has led to delays in receiving test results, which is particularly concerning for patients requiring urgent care. For instance, critical conditions like hyperkalemia were dangerously delayed in identification due to the IT failure.
Impact On Patients
The delay in receiving blood test results has significant ramifications for patients. Here are some of the ramifications of the delays:
Delays In Diagnosing Serious Conditions
One of the most significant impacts is the delay in identifying potentially dangerous or deteriorating health conditions. For example, in West Yorkshire, a major IT failure at Leeds Teaching Hospitals in 2024 led to the loss or mislabelling of tens of thousands of blood tests, says an article in The Times. One GP reported missing a case of hyperkalemia (dangerously high potassium levels), which could have resulted in a fatal cardiac event if not caught in time. The delay in this patient’s test results meant they were not treated promptly, putting them at direct risk.
Cancer Treatment Interrupted
Backlogs have also affected cancer care pathways, where early diagnosis is critical. Blood tests used in urgent cancer referrals (the two-week wait pathway) can be delayed, preventing timely scans, biopsies, or specialist appointments.
In some cases, patients with suspected blood cancers like leukemia or lymphoma have had to wait for diagnostic confirmation, delaying the start of potentially life-saving chemotherapy.
Emergency Departments Under Pressure
As a result of routine delays, some patients are turning to emergency services for help. Parents of children with chronic conditions such as epilepsy or autoimmune diseases have reported seeking care at A&E because they could not access timely test results through their GP or specialist. This increases pressure on already strained emergency departments and leads to inefficient use of healthcare resources.
Patient Anxiety And Loss Of Trust
Beyond the physical health consequences, delays in blood test results significantly impact mental health. Many patients report extreme anxiety while waiting for results, especially if they are being tested for conditions like cancer or heart disease. The uncertainty can lead to sleeplessness, panic attacks, and in some cases, a loss of confidence in the NHS. This can drive people toward private healthcare, even at significant personal cost.
Missed Monitoring For Chronic Conditions
For patients with ongoing conditions such as diabetes, kidney disease, or those on medications like anticoagulants or immunosuppressants, routine blood tests are essential to ensure treatment is working safely. Backlogs mean these checks are missed or significantly delayed, which can lead to unmanaged illness or medication toxicity. For instance, delayed INR tests for patients on warfarin could result in bleeding complications or increased stroke risk.
Efforts To Address The Backlog
In response to the situation, NHS Trusts are implementing measures to mitigate the impact of the delays. These include prioritising urgent cases, increasing staffing levels, and enhancing communication with patients regarding expected waiting times. However, the resolution of the backlog is contingent upon the restoration of full diagnostic capabilities and the resolution of supply chain issues.
Patients experiencing delays in blood tests are advised to maintain regular contact with their healthcare providers for updates on their test results and to seek alternative care if their condition deteriorates.
The current backlog of NHS blood tests highlights significant challenges within the healthcare system, including IT infrastructure failures and supply chain disruptions. Addressing these issues promptly is essential to ensure timely diagnosis and treatment for patients, thereby maintaining the quality and effectiveness of healthcare services.